Treatment of Bilateral Venous Thrombosis in a Patient with Aplasia of the Inferior Vena Cava

DOI: https://doi.org/10.30702/ujcvs/22.30(03)/KhT036-109114
Keywords: venous thromboembolism, bilateral iliofemoral deep vein thrombosis, anticoagulants, inferior vena cava syndrome, venous collaterals

Abstract

The aim. In the treatment of venous thromboembolism, a special place is occupied by patients with congenital anomalies of the development of the inferior vena cava (IVC). To date, only single cases of treatment of this pathology have been described in the literature. Studying the experience of treating patients with congenital anomalies of the IVC will allow to improve the results of treatment of this category of patients.

Materials and methods. Patient B., a 36-year-old man, applied to the vascular surgery clinic of the Vinnytsia Regional Pyrohov Clinical Hospital in July 2010 with complaints of pain, swelling, cyanosis of both lower extremities, which bothered the patient for about 10 days. The patient had no history of venous insufficiency of both lower extremities.

An objective examination revealed cyanosis and swelling of both lower extremities.

A duplex scan of both lower extremities revealed hyperechoic iliofemoral thrombosis of both lower extremities. Aplasia of the IVC was diagnosed. The common iliac veins on both sides formed a collateral that flowed into the left renal vein. The infrarenal segment of the inferior vena cava was absent. Thrombosis spread from tibial to popliteal, femoral, iliac veins with venous collateral thrombosis up to the level of the left renal vein.

The patient received enoxaparin at a dose of 1 mg per kg of body weight twice a day for 7 days with subsequent transition to warfarin under the control of international normalized ratio. Warfarin was prescribed from a starting dose of 5 mg with subsequent control of international normalized ratio in the range of 2.0-3.0. Venotonic and anti-inflammatory drugs were also prescribed. In combination with drug therapy, class 2 elastic compression stockings were recommended.

After the treatment, the patient’s condition improved, swelling and cyanosis of both lower extremities regressed. Repeated duplex scanning at the discharge of the patient from the hospital after 7 days showed signs of initial recanalization of the affected venous segments and no progression of thrombosis.

Conclusions. Thus, this clinical case showed that the use of anticoagulant therapy allows to obtain satisfactory results in the treatment of patients with congenital anomalies of the development of IVC, to avoid the development of pulmonary embolism and other life-threatening conditions. At the same time, such patients need regular follow-up examinations in order to adjust the treatment and prevent the development of IVC syndrome.

References

  1. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3-14. https://doi.org/10.1007/s11239-015-1311-6
  2. Woller B, Daw A, Aston V, Lloyd J, Snow G, Stevens SM, et al. Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System. Clin Appl Thromb Hemost. 2021;27:10760296211013108. https://doi.org/10.1177/10760296211013108
  3. Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis. Clin Exp Med. 2022 Apr 26 [E-pub ahead of print]. https://doi.org/10.1007/s10238-022-00829-w
  4. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340-7. https://doi.org/10.1161/CIRCRESAHA.115.306841
  5. Albricker ACL, Freire CMV, Santos SND, Alcantara ML, Saleh MH, Cantisano AL, et al. Joint Guideline on Venous Thromboembolism - 2022. Arq Bras Cardiol. 2022;118(4):797-857. https://doi.org/10.36660/abc.20220213
  6. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med. 2022;11(9):2533. https://doi.org/10.3390/jcm11092533
  7. Ryan L, Maharjan J, Mataraso S, Barnes G, Hoffman J, Mao Q, et al. Predicting pulmonary embolism among hospitalized patients with machine learning algorithms. Pulm Circ. 2022;12(1):e12013. https://doi.org/10.1002/pul2.12013
  8. Khrebtiy Y, Chernukha L. Is there a place for aggressive tactics in the treatment of deep vein thrombosis today? Clinical case of aspiration thrombectomy in the treatment of deep vein thrombosis. Acta Phlebol. 2021;22(2):61-8. https://doi.org/10.23736/S1593-232X.20.00476-2
  9. Chernuha LM, Skupii OM, Mitiuk OI, Khrebtiy YV. [Some Aspects of Treatment of Deep Venous Thrombosis of the Inferior Vena Cava System Complicated by Pulmonary Embolism – Opportunities and Outcomes]. Novosti Khirurgii. 2015;23(3):309-13. Russian. https://doi.org/10.18484/2305-0047.2015.3.309
  10. Mitiuk OI, Khrebtiĭ IaV. Application of cava-filter for prophylaxis of the pulmonary artery thromboembolism. Klin Khir. 2006;(10):63-4.
  11. Mitiuk OI, Khrebtiĭ IaV. Application of cava-filter for surgical prophylaxis of pulmonary thromboembolism. Klin Khir. 2007;(1):39-41.
  12. Khrebtiy YV. [An Integrated Approach to the Treatment of Pulmonary Embolism: Current State of the Problem]. Ukrainian Journal of Cardiovascular Surgery. 2022;30(2):39-43. Ukrainian. https://doi.org/10.30702/ujcvs/22.30(02)/Kh026-3943
  13. Malaki M, Willis AP, Jones RG. Congenital anomalies of the inferior vena cava. Clin Radiol. 2012;67(2):165-71. https://doi.org/10.1016/j.crad.2011.08.006
  14. Mazur AP, Todurov BM, Smorzhevskiĭ VI, Korolev AE, Kuz’mich IN. [Prophylaxis and treatment of a pulmonary artery thromboembolism]. Klin Khir. 2002;(10):27-30. Ukrainian.
  15. Morosetti D, Picchi E, Calcagni A, Lamacchia F, Cavallo AU, Bozzi A, et al. Anomalous development of the inferior vena cava: Case reports of agenesis and hypoplasia. Radiol Case Rep. 2018;13(4):895-903. https://doi.org/10.1016/j.radcr.2018.04.018
  16. Leitão A, Esteves JM, Abreu JP, Pereira AF, Boncoraglio MT, Certo M, et al. Deep Venous Thrombosis and a Very Rare Finding: Inferior Vena Cava Infra-renal Segment Agenesis. Eur J Case Rep Intern Med. 2019;6(3):001063. https://doi.org/10.12890/2019_001063
  17. Paddock M, Robson N. The curious case of the disappearing IVC: A case report and review of the aetiology of inferior Vena Cava Agenesis. J Radiol Case Rep. 2014;8(4):38-47. https://doi.org/10.3941/jrcr.v8i4.1572
  18. Lambert M, Marboeuf P, Midulla M, Trillot N, Beregi JP, Mounier-Vehier C, et al. Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature. Vasc Med. 2010;15(6):451-9. https://doi.org/10.1177/1358863X10391355
  19. Grillo VTRDS, Mellucci PL, Jaldin RG, Bertanha M, Pimenta REF, Sobreira ML. Agenesis of the infra-hepatic segment of the inferior vena cava associated with recurrent deep venous thrombosis: case report. J Vasc Bras. 2021;20:e20210006. https://doi.org/10.1590/1677-5449.210006
  20. Langer F, Dos Santos D, Suertegaray G, Haygert C. Bilateral Deep Vein Thrombosis Associated with Inferior Vena Cava Agenesis in a Young Patient Manifesting as Low Back Pain. Acta Med Port. 2017;30(4):333-7. https://doi.org/10.20344/amp.7744
  21. Pichon M, Hij A, Wifaq B, Abderrahmane M, El Jarrari M, Menn AM. [Deep venous thrombosis caused by congenital inferior vena cava agenesis]. J Med Vasc. 2019;44(1):79-85. French. https://doi.org/10.1016/j.jdmv.2018.11.005
  22. Van Laethem S, Peché R, Mercier V, Moradi M, Cauchie P, Van Meerhaeghe A. [Pulmonary embolism and inferior vena cava agenesis: An unusual association]. Rev Mal Respir. 2019;36(9):1069-72. French. https://doi.org/10.1016/j.rmr.2019.07.005
  23. Ramos Aranda J, Ramírez Cerda C, Cohen Mussali S, Valdés Flores J. Inferior Vena Cava Agenesis: An Unusual Cause of Deep Vein Thrombosis and Pulmonary Embolism in Young Adult Patients. EJVES Short Rep. 2018;39:12-5. https://doi.org/10.1016/j.ejvssr.2018.03.005
  24. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt- Montoya S, Black SA, et al. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9-82. https://doi.org/10.1016/j.ejvs.2020.09.023
  25. Partsch H, Kaulich M, Mayer W. Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome. Int Angiol. 2004;23(3):206-12.
  26. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med. 2017;377(23):2240-52. https://doi.org/10.1056/NEJMoa1615066
  27. Bækgaard N, Klitfod L, Broholm R. Safety and Efficacy of Catheter-directed Thrombolysis. Phlebology. 2012;27(Suppl 1):149-54. https://doi.org/10.1258/phleb.2012.012s15
  28. Zhou W, Rosenberg W, Lumsden A, Li J. Successful surgical management of pelvic congestion and lower extremity swelling owing to absence of infrarenal inferior vena cava. Vascular. 2005;13(6):358-61. https://doi.org/10.1258/rsmvasc.13.6.358
Published
2022-09-26
How to Cite
Khrebtiy, Y. V., Tsyhalko, D. V., & Melnychuk, M. O. (2022). Treatment of Bilateral Venous Thrombosis in a Patient with Aplasia of the Inferior Vena Cava. Ukrainian Journal of Cardiovascular Surgery, 30(3), 109-114. https://doi.org/10.30702/ujcvs/22.30(03)/KhT036-109114
Issue
Ukrainian Journal of Cardiovascular Surgery Vol 30 No 3 2022
Section
CASE REPORT